RSCI (Redwood Scientific Technologies) YoY EBITDA Growth: -1,700.00% (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Redwood Scientific Technologies YoY EBITDA Growth?

Redwood Scientific Technologies RSCI YoY EBITDA Growth is -1,700.00% as of Dec. 2023.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Redwood Scientific Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -1,700.00%.

Redwood Scientific Technologies's EBITDA per Share for the six months ended in Dec. 2023 was $-0.02.

Redwood Scientific Technologies YoY EBITDA Growth Related Terms

Redwood Scientific Technologies YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Redwood Scientific Technologies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies YoY EBITDA Growth Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
0.00 0.00 0.00 -1,700.00

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth 0.00 0.00 0.00 -1,700.00

Redwood Scientific Technologies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Redwood Scientific Technologies's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.018--0.001)/ | -0.001 |
=-1,700.00 %

Redwood Scientific Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 ) |
=(-0.018--0.001)/ | -0.001 |
=-1,700.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -1,700.00% mean?
Redwood Scientific Technologies (RSCI) has a YoY EBITDA Growth of -1,700.00% as of Dec. 2023. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Redwood Scientific Technologies and its competitors.
Is Redwood Scientific Technologies' YoY EBITDA Growth too high?
Redwood Scientific Technologies' current YoY EBITDA Growth is -1,700.00%.
How does Redwood Scientific Technologies' YoY EBITDA Growth compare to RAPH and FLGC?
Redwood Scientific Technologies' YoY EBITDA Growth of -1,700.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Redwood Scientific Technologies and its competitors. Redwood Scientific Technologies's current YoY EBITDA Growth is -1,700.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redwood Scientific Technologies stock overvalued right now?
Redwood Scientific Technologies (RSCI) has a current YoY EBITDA Growth of -1,700.00%. The current YoY EBITDA Growth is -1,700.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Redwood Scientific Technologies (RSCI), the current YoY EBITDA Growth is -1,700.00% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.